{
	"hits": [
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"787218\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This results in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches such as AI analysis.<br />\n\tNational Cancer Institute inventors developed an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This invention, related to another technology, E-084-2019, is updated to include a coated tape for holding and carrying sample sections as an alternative to a carrier film. The tape carries sequentially cut sample slices into a staining cassette where the slices are simultaneously stained directly on the tape. The tape carrying the stained samples are then fed into the imaging unit. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies. Automation is expected to reduce sample processing time ten-fold.<br />\n\tThe NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Biopsy sample processing in hospitals, pathology labs, research labs</li>\n<li>Diagnostics for various disease indications, including cancer and infectious diseases</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Facilitates processing and imaging of large volumes of pathology samples</li>\n<li>Automation is expected to reduce sample processing time ten-fold</li>\n<li>Automation increases reproducibility and minimizes errors</li>\n<li>Compatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</li>\n<li>Mounting and processing all sections of a sample on the same tape allows for an easier, more streamlined staining/imaging process</li>\n<li>Staining cassette is customizable</li>\n</ul><p> </p>\n</div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automatic System and Method for Tissue Sectioning, Staining, and Scanning\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-003-2022</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Young-Wan  Moon ((Micro Vizual Inc))</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael Pollack</a><br /><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael.Pollack@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 63/254,743 <br />Filed on 2021-10-12</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2022-12-13T12:00:00Z\" class=\"datetime\">Tue, 12/13/2022 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"787218\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-003-2022</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automatic System and Method for Tissue Sectioning, Staining, and Scanning\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Young-Wan  Moon ((Micro Vizual Inc))</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This results in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches such as AI analysis.<br />\n\tNational Cancer Institute inventors developed an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This invention, related to another technology, E-084-2019, is updated to include a coated tape for holding and carrying sample sections as an alternative to a carrier film. The tape carries sequentially cut sample slices into a staining cassette where the slices are simultaneously stained directly on the tape. The tape carrying the stained samples are then fed into the imaging unit. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies. Automation is expected to reduce sample processing time ten-fold.<br />\n\tThe NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Biopsy sample processing in hospitals, pathology labs, research labs</li>\n<li>Diagnostics for various disease indications, including cancer and infectious diseases</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Facilitates processing and imaging of large volumes of pathology samples</li>\n<li>Automation is expected to reduce sample processing time ten-fold</li>\n<li>Automation increases reproducibility and minimizes errors</li>\n<li>Compatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</li>\n<li>Mounting and processing all sections of a sample on the same tape allows for an easier, more streamlined staining/imaging process</li>\n<li>Staining cassette is customizable</li>\n</ul><p> </p>\n</div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael Pollack</a><br /><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael.Pollack@nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 63/254,743 <br />Filed on 2021-10-12</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2022-12-13T12:00:00Z\" class=\"datetime\">2022-12-13</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-003-2022", "body": "<p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This results in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches such as AI analysis.<br />\n\tNational Cancer Institute inventors developed an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This invention, related to another technology, E-084-2019, is updated to include a coated tape for holding and carrying sample sections as an alternative to a carrier film. The tape carries sequentially cut sample slices into a staining cassette where the slices are simultaneously stained directly on the tape. The tape carrying the stained samples are then fed into the imaging unit. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies. Automation is expected to reduce sample processing time ten-fold.<br />\n\tThe NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_co_inventors": "Young-Wan  Moon ((Micro Vizual Inc))", "field_collaboration_description": "Licensing only", "field_collaborations": "Licensing Desired", "field_commercial_applications": "<ul><li>Biopsy sample processing in hospitals, pathology labs, research labs</li>\n<li>Diagnostics for various disease indications, including cancer and infectious diseases</li>\n</ul>", "field_competitive_advantages": "<ul><li>Facilitates processing and imaging of large volumes of pathology samples</li>\n<li>Automation is expected to reduce sample processing time ten-fold</li>\n<li>Automation increases reproducibility and minimizes errors</li>\n<li>Compatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</li>\n<li>Mounting and processing all sections of a sample on the same tape allows for an easier, more streamlined staining/imaging process</li>\n<li>Staining cassette is customizable</li>\n</ul><p> </p>\n", "field_data_source": "nci", "field_data_source_id": "NCI-E-003-2022", "field_date_published": 1670932800, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-003-2022", "field_inventors": ["Young-Wan  Moon ((Micro Vizual Inc))", "Zhengping Zhuang (NCI)"], "nid": 787218, "status": true, "title": "Automatic System and Method for Tissue Sectioning, Staining, and Scanning", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/787218:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/787218:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Computer and imaging technologies led to the development of", "matchLevel": "none" }, "body": { "value": "Computer and imaging technologies led to the development of digital", "matchLevel": "none" }, "field_id": { "value": "NCI-E-003-2022", "matchLevel": "none" }, "title": { "value": "Automatic System and Method for Tissue Sectioning, Staining, and Scanning", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"787218\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This results in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches such as AI analysis.<br />\n\tNational Cancer Institute inventors developed an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This invention, related to another technology, E-084-2019, is updated to include a coated tape for holding and carrying sample sections as an alternative to a carrier film. The tape carries sequentially cut sample slices into a staining cassette where the slices are simultaneously stained directly on the tape. The tape carrying the stained samples are then fed into the imaging unit. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies. Automation is expected to reduce sample processing time ten-fold.<br />\n\tThe NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Biopsy sample processing in hospitals, pathology labs, research labs</li>\n<li>Diagnostics for various disease indications, including cancer and infectious diseases</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Facilitates processing and imaging of large volumes of pathology samples</li>\n<li>Automation is expected to reduce sample processing time ten-fold</li>\n<li>Automation increases reproducibility and minimizes errors</li>\n<li>Compatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</li>\n<li>Mounting and processing all sections of a sample on the same tape allows for an easier, more streamlined staining/imaging process</li>\n<li>Staining cassette is customizable</li>\n</ul><p> </p>\n</div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automatic System and Method for Tissue Sectioning, Staining, and Scanning\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-003-2022</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Young-Wan  Moon ((Micro Vizual Inc))</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael Pollack</a><br /><a href=\"mailto:Michael.Pollack@nih.gov?subject=Web Inquiry regarding [NCI-E-003-2022]\">Michael.Pollack@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 63/254,743 <br />Filed on 2021-10-12</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2022-12-13T12:00:00Z\" class=\"datetime\">Tue, 12/13/2022 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This results in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches such as AI analysis.<br />\n\tNational Cancer Institute inventors developed an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This invention, related to another technology, E-084-2019, is updated to include a coated tape for holding and carrying sample sections as an alternative to a carrier film. The tape carries sequentially cut sample slices into a staining cassette where the slices are simultaneously stained directly on the tape. The tape carrying the stained samples are then fed into the imaging unit. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies. Automation is expected to reduce sample processing time ten-fold.<br />\n\tThe NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-003-2022", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Automatic System and Method for Tissue Sectioning, Staining, and Scanning", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"787177\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This resulted in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of the techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches like AI analysis.</p>\n<p>National Cancer Institute inventors are developing an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies.</p>\n<p>The NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><p>Biopsy sample processing in pathology labs, hospitals, research labs<br />\n\tApplicable to diagnoses of various disease indications, including cancer and infectious diseases</p>\n</div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><p>Facilitates processing and imaging of large volumes of pathology samples<br />\n\tAutomation saves time, increases reproducibility, and minimizes errors<br />\n\tCompatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</p>\n</div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automated Digital Pathology Device for High-Throughput Demand\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-084-2019</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Anthony Cappadona (NCI)</div>\n          <div class=\"field__item\">Young-Won Moon (AIPATec Inc)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">Michael Salgaller, Ph.D.</a><br /><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">michael.salgaller@nih.gov</a><br />Phone: 240-276-5476<br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application US2020/023644 <br />Filed on 2020-03-19</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2021-09-23T12:00:00Z\" class=\"datetime\">Thu, 09/23/2021 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"787177\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-084-2019</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automated Digital Pathology Device for High-Throughput Demand\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Anthony Cappadona (NCI)</div>\n          <div class=\"field__item\">Young-Won Moon (AIPATec Inc)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This resulted in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of the techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches like AI analysis.</p>\n<p>National Cancer Institute inventors are developing an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies.</p>\n<p>The NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><p>Biopsy sample processing in pathology labs, hospitals, research labs<br />\n\tApplicable to diagnoses of various disease indications, including cancer and infectious diseases</p>\n</div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><p>Facilitates processing and imaging of large volumes of pathology samples<br />\n\tAutomation saves time, increases reproducibility, and minimizes errors<br />\n\tCompatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</p>\n</div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">Michael Salgaller, Ph.D.</a><br /><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">michael.salgaller@nih.gov</a><br />Phone: 240-276-5476<br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application US2020/023644 <br />Filed on 2020-03-19</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2021-09-23T12:00:00Z\" class=\"datetime\">2021-09-23</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-084-2019", "body": "<p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This resulted in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of the techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches like AI analysis.</p>\n<p>National Cancer Institute inventors are developing an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies.</p>\n<p>The NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_co_inventors": ["Anthony Cappadona (NCI)", "Young-Won Moon (AIPATec Inc)"], "field_collaboration_description": "Licensing only", "field_collaborations": "Licensing Desired", "field_commercial_applications": "<p>Biopsy sample processing in pathology labs, hospitals, research labs<br />\n\tApplicable to diagnoses of various disease indications, including cancer and infectious diseases</p>\n", "field_competitive_advantages": "<p>Facilitates processing and imaging of large volumes of pathology samples<br />\n\tAutomation saves time, increases reproducibility, and minimizes errors<br />\n\tCompatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</p>\n", "field_data_source": "nci", "field_data_source_id": "NCI-E-084-2019", "field_date_published": 1632398400, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-084-2019", "field_inventors": ["Anthony Cappadona (NCI)", "Young-Won Moon (AIPATec Inc)", "Zhengping Zhuang (NCI)"], "nid": 787177, "status": true, "title": "Automated Digital Pathology Device for High-Throughput Demand", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/787177:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/787177:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Computer and imaging technologies led to the development of", "matchLevel": "none" }, "body": { "value": "Computer and imaging technologies led to the development of digital", "matchLevel": "none" }, "field_id": { "value": "NCI-E-084-2019", "matchLevel": "none" }, "title": { "value": "Automated Digital Pathology Device for High-Throughput Demand", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"787177\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This resulted in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of the techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches like AI analysis.</p>\n<p>National Cancer Institute inventors are developing an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies.</p>\n<p>The NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><p>Biopsy sample processing in pathology labs, hospitals, research labs<br />\n\tApplicable to diagnoses of various disease indications, including cancer and infectious diseases</p>\n</div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><p>Facilitates processing and imaging of large volumes of pathology samples<br />\n\tAutomation saves time, increases reproducibility, and minimizes errors<br />\n\tCompatible with high-throughput processes, e.g., AI analysis of digital pathology images and 3D reconstruction</p>\n</div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Automated Digital Pathology Device for High-Throughput Demand\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-084-2019</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Zhengping Zhuang (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Anthony Cappadona (NCI)</div>\n          <div class=\"field__item\">Young-Won Moon (AIPATec Inc)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">Michael Salgaller, Ph.D.</a><br /><a href=\"mailto:michael.salgaller@nih.gov?subject=Web Inquiry regarding [NCI-E-084-2019]\">michael.salgaller@nih.gov</a><br />Phone: 240-276-5476<br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application US2020/023644 <br />Filed on 2020-03-19</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2021-09-23T12:00:00Z\" class=\"datetime\">Thu, 09/23/2021 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Computer and imaging technologies led to the development of digital pathology and the capture and storage of pathological specimens as digitally formatted images. The use of artificial intelligence (AI) in digital pathology, such as in three-dimensional (3D) reconstruction, requires analyses of high volumes of data. This resulted in increased demands for processing and acquisition of digital images of pathology samples. Increased usage cannot be met by the time-consuming, manual, and laborious methods currently used. Therefore, there is a need for automation of the techniques used in processing of pathology samples and acquisition of digital images to make them amenable with high-throughput approaches like AI analysis.</p>\n<p>National Cancer Institute inventors are developing an automated device with integrated tissue sectioning, staining, scanning, and high-throughput capability. This device integrates pathology sample processing (e.g., sectioning, fixing, and staining) with optical scanning and digital image acquisition. This streamlines the entire process enabling high-throughput preparation of large volumes of samples and data for subsequent AI analysis. As a result of automation, the device saves time, minimizes errors, and reduces wasting reagents and supplies.</p>\n<p>The NCI is seeking licensees to develop an automated digital pathology device compatible with high-throughput data analysis.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-084-2019", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Automated Digital Pathology Device for High-Throughput Demand", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"787040\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>The ability to hold and transport tissue, especially needle biopsies in a pre-defined and controlled environment is critical for the preservation of biopsy samples in downstream analytic applications. Currently, tissue specimens are placed in open containers with variable, poorly controlled solutions applied to them, often in less than sterile conditions.  Evaluation of the tissue by examination through a stereoscope or similar approaches to determine adequacy is limited and requires manipulation of the tissue that can further damage the tissue. The entire process lacks standardization, which is in stark contrast to the handling of blood, that is collected and transported in well-defined containers that have individualized pre-analytic preservatives and downstream protocols. <br />\n\t <br />\n\tResearchers at National Institutes of Health (NIH) have developed a tissue collection and storage container that allows for the direct deposition of tissue into the container while stabilizing the sample for transport in a specific solution and/or gas. This new device will primarily be used for needle biopsies to collect tissue samples and maintain their integrity for subsequent analysis. Additional features of the tissue storage container will include materials to physically stabilize and allow for direct examination of the sample by microscopy.</p>\n<p>This system is available for co-development or licensing to interested companies.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Tissue storage container for collecting samples obtained by biopsy gun, manual biopsy, or interventional radiology such as computed tomography (CT)-guided transvascular, transcutaneous, transvascular sampling, or needle aspiration</li>\n<li>Sterile and controlled storage environment for the transport of tissue, cell, and liquid samples. Can be combined with the tissue fixative agent, BE70 [<a href=\"https://techtransfer.cancer.gov/availabletechnologies/e-139-2015\">NIH Reference # E-139-2015</a>]</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>No devices currently allow for tissue storage in a sterile, pre-defined, and controlled environment, and can be used to prepare the sample for further analysis</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-128-2017</div>\n          </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Armando Filie (NCI)</div>\n          <div class=\"field__item\">Hiroshi Kojima (NIDDK)</div>\n          <div class=\"field__item\">Jeffrey Hanson (NCI)</div>\n          <div class=\"field__item\">Robert Star (NIDDK)</div>\n          <div class=\"field__item\">Russell Bandle (NCI)</div>\n          <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NIDDK\" hreflang=\"und\">NIDDK</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 62/490,415 <br />Filed on 2017-04-26</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2018-09-05T12:00:00Z\" class=\"datetime\">Wed, 09/05/2018 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"787040\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-128-2017</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Armando Filie (NCI)</div>\n          <div class=\"field__item\">Hiroshi Kojima (NIDDK)</div>\n          <div class=\"field__item\">Jeffrey Hanson (NCI)</div>\n          <div class=\"field__item\">Robert Star (NIDDK)</div>\n          <div class=\"field__item\">Russell Bandle (NCI)</div>\n          <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NIDDK\" hreflang=\"und\">NIDDK</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>The ability to hold and transport tissue, especially needle biopsies in a pre-defined and controlled environment is critical for the preservation of biopsy samples in downstream analytic applications. Currently, tissue specimens are placed in open containers with variable, poorly controlled solutions applied to them, often in less than sterile conditions.  Evaluation of the tissue by examination through a stereoscope or similar approaches to determine adequacy is limited and requires manipulation of the tissue that can further damage the tissue. The entire process lacks standardization, which is in stark contrast to the handling of blood, that is collected and transported in well-defined containers that have individualized pre-analytic preservatives and downstream protocols. <br />\n\t <br />\n\tResearchers at National Institutes of Health (NIH) have developed a tissue collection and storage container that allows for the direct deposition of tissue into the container while stabilizing the sample for transport in a specific solution and/or gas. This new device will primarily be used for needle biopsies to collect tissue samples and maintain their integrity for subsequent analysis. Additional features of the tissue storage container will include materials to physically stabilize and allow for direct examination of the sample by microscopy.</p>\n<p>This system is available for co-development or licensing to interested companies.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Tissue storage container for collecting samples obtained by biopsy gun, manual biopsy, or interventional radiology such as computed tomography (CT)-guided transvascular, transcutaneous, transvascular sampling, or needle aspiration</li>\n<li>Sterile and controlled storage environment for the transport of tissue, cell, and liquid samples. Can be combined with the tissue fixative agent, BE70 [<a href=\"https://techtransfer.cancer.gov/availabletechnologies/e-139-2015\">NIH Reference # E-139-2015</a>]</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>No devices currently allow for tissue storage in a sterile, pre-defined, and controlled environment, and can be used to prepare the sample for further analysis</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 62/490,415 <br />Filed on 2017-04-26</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2018-09-05T12:00:00Z\" class=\"datetime\">2018-09-05</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-128-2017", "body": "<p>The ability to hold and transport tissue, especially needle biopsies in a pre-defined and controlled environment is critical for the preservation of biopsy samples in downstream analytic applications. Currently, tissue specimens are placed in open containers with variable, poorly controlled solutions applied to them, often in less than sterile conditions.  Evaluation of the tissue by examination through a stereoscope or similar approaches to determine adequacy is limited and requires manipulation of the tissue that can further damage the tissue. The entire process lacks standardization, which is in stark contrast to the handling of blood, that is collected and transported in well-defined containers that have individualized pre-analytic preservatives and downstream protocols. <br />\n\t <br />\n\tResearchers at National Institutes of Health (NIH) have developed a tissue collection and storage container that allows for the direct deposition of tissue into the container while stabilizing the sample for transport in a specific solution and/or gas. This new device will primarily be used for needle biopsies to collect tissue samples and maintain their integrity for subsequent analysis. Additional features of the tissue storage container will include materials to physically stabilize and allow for direct examination of the sample by microscopy.</p>\n<p>This system is available for co-development or licensing to interested companies.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_co_inventors": ["Armando Filie (NCI)", "Hiroshi Kojima (NIDDK)", "Jeffrey Hanson (NCI)", "Robert Star (NIDDK)", "Russell Bandle (NCI)", "Stephen Hewitt (NCI)"], "field_collaboration_description": "Licensing and research collaboration", "field_collaborations": ["Licensing Desired", "Licensing & Collaboration Desired", "Collaboration Sought"], "field_commercial_applications": "<ul><li>Tissue storage container for collecting samples obtained by biopsy gun, manual biopsy, or interventional radiology such as computed tomography (CT)-guided transvascular, transcutaneous, transvascular sampling, or needle aspiration</li>\n<li>Sterile and controlled storage environment for the transport of tissue, cell, and liquid samples. Can be combined with the tissue fixative agent, BE70 [<a href=\"https://techtransfer.cancer.gov/availabletechnologies/e-139-2015\">NIH Reference # E-139-2015</a>]</li>\n</ul>", "field_competitive_advantages": "<ul><li>No devices currently allow for tissue storage in a sterile, pre-defined, and controlled environment, and can be used to prepare the sample for further analysis</li>\n</ul>", "field_data_source": "nci", "field_data_source_id": "NCI-E-128-2017", "field_date_published": 1536148800, "field_ics": ["NIDDK", "NCI"], "field_ics_id": [202, 189], "field_id": "NCI-E-128-2017", "field_inventors": ["Armando Filie (NCI)", "Hiroshi Kojima (NIDDK)", "Jeffrey Hanson (NCI)", "Robert Star (NIDDK)", "Russell Bandle (NCI)", "Stephen Hewitt (NCI)"], "nid": 787040, "status": true, "title": "A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/787040:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/787040:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            The ability to hold and transport tissue, especially needle", "matchLevel": "none" }, "body": { "value": "The ability to hold and transport tissue, especially needle biopsies", "matchLevel": "none" }, "field_id": { "value": "NCI-E-128-2017", "matchLevel": "none" }, "title": { "value": "A Specialized Tissue Collection Device for the Preservation and Transportation", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"787040\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>The ability to hold and transport tissue, especially needle biopsies in a pre-defined and controlled environment is critical for the preservation of biopsy samples in downstream analytic applications. Currently, tissue specimens are placed in open containers with variable, poorly controlled solutions applied to them, often in less than sterile conditions.  Evaluation of the tissue by examination through a stereoscope or similar approaches to determine adequacy is limited and requires manipulation of the tissue that can further damage the tissue. The entire process lacks standardization, which is in stark contrast to the handling of blood, that is collected and transported in well-defined containers that have individualized pre-analytic preservatives and downstream protocols. <br />\n\t <br />\n\tResearchers at National Institutes of Health (NIH) have developed a tissue collection and storage container that allows for the direct deposition of tissue into the container while stabilizing the sample for transport in a specific solution and/or gas. This new device will primarily be used for needle biopsies to collect tissue samples and maintain their integrity for subsequent analysis. Additional features of the tissue storage container will include materials to physically stabilize and allow for direct examination of the sample by microscopy.</p>\n<p>This system is available for co-development or licensing to interested companies.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Tissue storage container for collecting samples obtained by biopsy gun, manual biopsy, or interventional radiology such as computed tomography (CT)-guided transvascular, transcutaneous, transvascular sampling, or needle aspiration</li>\n<li>Sterile and controlled storage environment for the transport of tissue, cell, and liquid samples. Can be combined with the tissue fixative agent, BE70 [<a href=\"https://techtransfer.cancer.gov/availabletechnologies/e-139-2015\">NIH Reference # E-139-2015</a>]</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>No devices currently allow for tissue storage in a sterile, pre-defined, and controlled environment, and can be used to prepare the sample for further analysis</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-128-2017</div>\n          </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Armando Filie (NCI)</div>\n          <div class=\"field__item\">Hiroshi Kojima (NIDDK)</div>\n          <div class=\"field__item\">Jeffrey Hanson (NCI)</div>\n          <div class=\"field__item\">Robert Star (NIDDK)</div>\n          <div class=\"field__item\">Russell Bandle (NCI)</div>\n          <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Prototype</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NIDDK\" hreflang=\"und\">NIDDK</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-128-2017]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"> Application 62/490,415 <br />Filed on 2017-04-26</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2018-09-05T12:00:00Z\" class=\"datetime\">Wed, 09/05/2018 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>The ability to hold and transport tissue, especially needle biopsies in a pre-defined and controlled environment is critical for the preservation of biopsy samples in downstream analytic applications. Currently, tissue specimens are placed in open containers with variable, poorly controlled solutions applied to them, often in less than sterile conditions.  Evaluation of the tissue by examination through a stereoscope or similar approaches to determine adequacy is limited and requires manipulation of the tissue that can further damage the tissue. The entire process lacks standardization, which is in stark contrast to the handling of blood, that is collected and transported in well-defined containers that have individualized pre-analytic preservatives and downstream protocols. <br />\n\t <br />\n\tResearchers at National Institutes of Health (NIH) have developed a tissue collection and storage container that allows for the direct deposition of tissue into the container while stabilizing the sample for transport in a specific solution and/or gas. This new device will primarily be used for needle biopsies to collect tissue samples and maintain their integrity for subsequent analysis. Additional features of the tissue storage container will include materials to physically stabilize and allow for direct examination of the sample by microscopy.</p>\n<p>This system is available for co-development or licensing to interested companies.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-128-2017", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "A Specialized Tissue Collection Device for the Preservation and Transportation of Needle Biopsies", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"786900\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissue obtained for both clinical and research purposes is routinely frozen, commonly in Optimal Cutting Temperature (OCT), an embedding media, for eventual downstream analysis, commonly including sectioning on a cryostat. Though OCT is the standard compound used for freezing, there is no standard freezing protocol. Thus, current methods of handling, labeling, and storing OCT-embedded tissue vary widely, and specimens are often damaged or degraded due to undesirable temperature fluctuations during handling and freezing.</p>\n<p>To address these issues, researchers from the NCI <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology (LP)</a> have engineered a system that employs a plastic enclosure that also functions as a tissue platen for cryosectioning, which is then enclosed with a lid for storage. This plastic enclosure also has an integrated space for labeling (written, barcode, RFID, etc.). The lid snaps closed to protect the specimen from deformation and/or thermal shock. This ‘freezing system’ is particularly unique since it is modular (i.e. designed to fit in commonly used research/clinical storage units) and affordable. Additionally, the module can be designed to work with any manufacturer’s tissue holders for cryosectioning.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>This is a novel enclosure that provides a standardized method of freezing, labeling, and storing fresh tissue samples for diagnostic and/or research purposes</li>\n<li>This ‘freezing system’ would be particularly useful for rare or fragile specimens, since it can significantly reduce the possibility of deformation or thermal shock</li>\n<li>Tissue is frozen as a sandwich directly onto plastic enclosure, using an OCT and a pre-existing mold </li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>This is a novel device that addresses an unmet need in frozen tissue storage and evaluation</li>\n<li>Enclosure has integrated external labeling, for minimal disturbance of sample</li>\n<li>Enclosure has a snap-closed lid for added sample protection</li>\n<li>Enclosure is plastic–insulative properties (i.e. slow to adjust to changes in external temperature)</li>\n<li>Enclosure is modular and versatile; it will fit in most commonly used storage units in research and clinical settings</li>\n<li>Enclosure is affordable; each unit is designed for single use</li>\n<li>A model is available for clinical application, in which a frozen specimen can be subject to cryosectioning and then directly enclosed into an open unit for immediate fixation and processing as formalin fixed, paraffin embedded tissue, for confirmation of diagnosis</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Module to Freeze and Store Frozen Tissue\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-173-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/403,585 <br />Filed on 2016-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-08-03T12:00:00Z\" class=\"datetime\">Thu, 08/03/2017 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"786900\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-173-2015</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Module to Freeze and Store Frozen Tissue\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissue obtained for both clinical and research purposes is routinely frozen, commonly in Optimal Cutting Temperature (OCT), an embedding media, for eventual downstream analysis, commonly including sectioning on a cryostat. Though OCT is the standard compound used for freezing, there is no standard freezing protocol. Thus, current methods of handling, labeling, and storing OCT-embedded tissue vary widely, and specimens are often damaged or degraded due to undesirable temperature fluctuations during handling and freezing.</p>\n<p>To address these issues, researchers from the NCI <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology (LP)</a> have engineered a system that employs a plastic enclosure that also functions as a tissue platen for cryosectioning, which is then enclosed with a lid for storage. This plastic enclosure also has an integrated space for labeling (written, barcode, RFID, etc.). The lid snaps closed to protect the specimen from deformation and/or thermal shock. This ‘freezing system’ is particularly unique since it is modular (i.e. designed to fit in commonly used research/clinical storage units) and affordable. Additionally, the module can be designed to work with any manufacturer’s tissue holders for cryosectioning.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>This is a novel enclosure that provides a standardized method of freezing, labeling, and storing fresh tissue samples for diagnostic and/or research purposes</li>\n<li>This ‘freezing system’ would be particularly useful for rare or fragile specimens, since it can significantly reduce the possibility of deformation or thermal shock</li>\n<li>Tissue is frozen as a sandwich directly onto plastic enclosure, using an OCT and a pre-existing mold </li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>This is a novel device that addresses an unmet need in frozen tissue storage and evaluation</li>\n<li>Enclosure has integrated external labeling, for minimal disturbance of sample</li>\n<li>Enclosure has a snap-closed lid for added sample protection</li>\n<li>Enclosure is plastic–insulative properties (i.e. slow to adjust to changes in external temperature)</li>\n<li>Enclosure is modular and versatile; it will fit in most commonly used storage units in research and clinical settings</li>\n<li>Enclosure is affordable; each unit is designed for single use</li>\n<li>A model is available for clinical application, in which a frozen specimen can be subject to cryosectioning and then directly enclosed into an open unit for immediate fixation and processing as formalin fixed, paraffin embedded tissue, for confirmation of diagnosis</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/403,585 <br />Filed on 2016-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-08-03T12:00:00Z\" class=\"datetime\">2017-08-03</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-173-2015", "body": "<p>Tissue obtained for both clinical and research purposes is routinely frozen, commonly in Optimal Cutting Temperature (OCT), an embedding media, for eventual downstream analysis, commonly including sectioning on a cryostat. Though OCT is the standard compound used for freezing, there is no standard freezing protocol. Thus, current methods of handling, labeling, and storing OCT-embedded tissue vary widely, and specimens are often damaged or degraded due to undesirable temperature fluctuations during handling and freezing.</p>\n<p>To address these issues, researchers from the NCI <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology (LP)</a> have engineered a system that employs a plastic enclosure that also functions as a tissue platen for cryosectioning, which is then enclosed with a lid for storage. This plastic enclosure also has an integrated space for labeling (written, barcode, RFID, etc.). The lid snaps closed to protect the specimen from deformation and/or thermal shock. This ‘freezing system’ is particularly unique since it is modular (i.e. designed to fit in commonly used research/clinical storage units) and affordable. Additionally, the module can be designed to work with any manufacturer’s tissue holders for cryosectioning.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_collaboration_description": "Licensing and research collaboration", "field_collaborations": ["Licensing Desired", "Licensing & Collaboration Desired", "Collaboration Sought"], "field_commercial_applications": "<ul><li>This is a novel enclosure that provides a standardized method of freezing, labeling, and storing fresh tissue samples for diagnostic and/or research purposes</li>\n<li>This ‘freezing system’ would be particularly useful for rare or fragile specimens, since it can significantly reduce the possibility of deformation or thermal shock</li>\n<li>Tissue is frozen as a sandwich directly onto plastic enclosure, using an OCT and a pre-existing mold </li>\n</ul>", "field_competitive_advantages": "<ul><li>This is a novel device that addresses an unmet need in frozen tissue storage and evaluation</li>\n<li>Enclosure has integrated external labeling, for minimal disturbance of sample</li>\n<li>Enclosure has a snap-closed lid for added sample protection</li>\n<li>Enclosure is plastic–insulative properties (i.e. slow to adjust to changes in external temperature)</li>\n<li>Enclosure is modular and versatile; it will fit in most commonly used storage units in research and clinical settings</li>\n<li>Enclosure is affordable; each unit is designed for single use</li>\n<li>A model is available for clinical application, in which a frozen specimen can be subject to cryosectioning and then directly enclosed into an open unit for immediate fixation and processing as formalin fixed, paraffin embedded tissue, for confirmation of diagnosis</li>\n</ul>", "field_data_source": "nci", "field_data_source_id": "NCI-E-173-2015", "field_date_published": 1501761600, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-173-2015", "field_inventors": "Stephen Hewitt (NCI)", "nid": 786900, "status": true, "title": "Module to Freeze and Store Frozen Tissue", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/786900:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/786900:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Tissue obtained for both clinical and research purposes is", "matchLevel": "none" }, "body": { "value": "Tissue obtained for both clinical and research purposes is routinely", "matchLevel": "none" }, "field_id": { "value": "NCI-E-173-2015", "matchLevel": "none" }, "title": { "value": "Module to Freeze and Store Frozen Tissue", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"786900\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissue obtained for both clinical and research purposes is routinely frozen, commonly in Optimal Cutting Temperature (OCT), an embedding media, for eventual downstream analysis, commonly including sectioning on a cryostat. Though OCT is the standard compound used for freezing, there is no standard freezing protocol. Thus, current methods of handling, labeling, and storing OCT-embedded tissue vary widely, and specimens are often damaged or degraded due to undesirable temperature fluctuations during handling and freezing.</p>\n<p>To address these issues, researchers from the NCI <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology (LP)</a> have engineered a system that employs a plastic enclosure that also functions as a tissue platen for cryosectioning, which is then enclosed with a lid for storage. This plastic enclosure also has an integrated space for labeling (written, barcode, RFID, etc.). The lid snaps closed to protect the specimen from deformation and/or thermal shock. This ‘freezing system’ is particularly unique since it is modular (i.e. designed to fit in commonly used research/clinical storage units) and affordable. Additionally, the module can be designed to work with any manufacturer’s tissue holders for cryosectioning.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>This is a novel enclosure that provides a standardized method of freezing, labeling, and storing fresh tissue samples for diagnostic and/or research purposes</li>\n<li>This ‘freezing system’ would be particularly useful for rare or fragile specimens, since it can significantly reduce the possibility of deformation or thermal shock</li>\n<li>Tissue is frozen as a sandwich directly onto plastic enclosure, using an OCT and a pre-existing mold </li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>This is a novel device that addresses an unmet need in frozen tissue storage and evaluation</li>\n<li>Enclosure has integrated external labeling, for minimal disturbance of sample</li>\n<li>Enclosure has a snap-closed lid for added sample protection</li>\n<li>Enclosure is plastic–insulative properties (i.e. slow to adjust to changes in external temperature)</li>\n<li>Enclosure is modular and versatile; it will fit in most commonly used storage units in research and clinical settings</li>\n<li>Enclosure is affordable; each unit is designed for single use</li>\n<li>A model is available for clinical application, in which a frozen specimen can be subject to cryosectioning and then directly enclosed into an open unit for immediate fixation and processing as formalin fixed, paraffin embedded tissue, for confirmation of diagnosis</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Module to Freeze and Store Frozen Tissue\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-173-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-173-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/403,585 <br />Filed on 2016-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-08-03T12:00:00Z\" class=\"datetime\">Thu, 08/03/2017 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Tissue obtained for both clinical and research purposes is routinely frozen, commonly in Optimal Cutting Temperature (OCT), an embedding media, for eventual downstream analysis, commonly including sectioning on a cryostat. Though OCT is the standard compound used for freezing, there is no standard freezing protocol. Thus, current methods of handling, labeling, and storing OCT-embedded tissue vary widely, and specimens are often damaged or degraded due to undesirable temperature fluctuations during handling and freezing.</p>\n<p>To address these issues, researchers from the NCI <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology (LP)</a> have engineered a system that employs a plastic enclosure that also functions as a tissue platen for cryosectioning, which is then enclosed with a lid for storage. This plastic enclosure also has an integrated space for labeling (written, barcode, RFID, etc.). The lid snaps closed to protect the specimen from deformation and/or thermal shock. This ‘freezing system’ is particularly unique since it is modular (i.e. designed to fit in commonly used research/clinical storage units) and affordable. Additionally, the module can be designed to work with any manufacturer’s tissue holders for cryosectioning.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-173-2015", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Module to Freeze and Store Frozen Tissue", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"786880\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Bacterial spores can be modified to display molecules of interest, including drugs, immunogenic peptides, antibodies and other functional proteins of interest (such as enzymes).  The resulting engineered bacterial spores can provide many useful functions such as the treatment of infections, use as an adjuvant for the delivery of vaccines, and the enzymatic degradation of environmental pollutants.</p>\n<p>Researchers at the National Cancer Institute’s (NCI) <a href=\"https://ccr.cancer.gov/Laboratory-of-Molecular-Biology\" rel=\"nofollow\">Laboratory of Molecular Biology</a> have developed a novel, synthetic spore husk-encased lipid bilayer (SSHEL) particle that is uniquely suited for a variety of these functions. The assembly of SSHELs involves the insertion of the bacterial spore coat protein SpoVM into a lipid bilayer that is located on a synthetic core particle.  SpoVM serves as a structural element and recruitment factor for the bacterial spore coat protein SpoIVA.  When SpoIVA is conjugated to streptavidin, the SSHEL can bind to another molecule through a biotin linkage.  This leads to the creation of a specialized SSHEL that can serve a particular biological function.  The lab's pre-clinical work has demonstrated that SSHELs loaded with Doxorubicin reduced the tumor burden in a mouse tumor xenograft model of HER2-positive ovarian cancer.  By varying the ratio of streptavidin-conjugated and unconjugated SpoIVA protein used in the manufacture of the SSHEL, it is possible to tailor the amount of functional molecule that is present in the SSHEL.  This affords greater control over the level of activity that is provided by the SSHEL, thereby allowing the fine tuning of its function.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Applications for this technology are only limited by the molecules bound to the nanoparticle (SSHEL)</li>\n<li>Use of SSHELs that display a therapeutic agent to treat a disease, e.g. Doxorubicin for HER2-positive cancer</li>\n<li>Use of SSHELs to deliver vaccines to patients</li>\n<li>Use of SSHELs to provide particles with enzymatic functions</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>The ability to display multiple types of therapeutic agents provides diversity of function</li>\n<li>The ability to vary the amount of SpoIVA that can bind to a functional agent (e.g. Doxorubicin through a streptavidin-biotin interaction) allows fine tuning, high targeting efficiency, and reduced toxicity</li>\n<li>Lack of extraneous cell surface proteins on SSHELs avoids potential interference between the SSHEL and its target</li>\n<li>Non-living delivery system avoids complications associated with using a living organism</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-098-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Kumaran Ramamurthi (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">David Lambertson</a><br /><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">david.lambertson@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/127,738 <br />Filed on 2015-03-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Wu et al. A Versatile Nano-Display Platform from Bacterial Spore Coat Proteins<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25854653\">PMID: 25854653</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-03-23T12:00:00Z\" class=\"datetime\">Thu, 03/23/2017 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"786880\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-098-2015</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Kumaran Ramamurthi (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Bacterial spores can be modified to display molecules of interest, including drugs, immunogenic peptides, antibodies and other functional proteins of interest (such as enzymes).  The resulting engineered bacterial spores can provide many useful functions such as the treatment of infections, use as an adjuvant for the delivery of vaccines, and the enzymatic degradation of environmental pollutants.</p>\n<p>Researchers at the National Cancer Institute’s (NCI) <a href=\"https://ccr.cancer.gov/Laboratory-of-Molecular-Biology\" rel=\"nofollow\">Laboratory of Molecular Biology</a> have developed a novel, synthetic spore husk-encased lipid bilayer (SSHEL) particle that is uniquely suited for a variety of these functions. The assembly of SSHELs involves the insertion of the bacterial spore coat protein SpoVM into a lipid bilayer that is located on a synthetic core particle.  SpoVM serves as a structural element and recruitment factor for the bacterial spore coat protein SpoIVA.  When SpoIVA is conjugated to streptavidin, the SSHEL can bind to another molecule through a biotin linkage.  This leads to the creation of a specialized SSHEL that can serve a particular biological function.  The lab's pre-clinical work has demonstrated that SSHELs loaded with Doxorubicin reduced the tumor burden in a mouse tumor xenograft model of HER2-positive ovarian cancer.  By varying the ratio of streptavidin-conjugated and unconjugated SpoIVA protein used in the manufacture of the SSHEL, it is possible to tailor the amount of functional molecule that is present in the SSHEL.  This affords greater control over the level of activity that is provided by the SSHEL, thereby allowing the fine tuning of its function.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Applications for this technology are only limited by the molecules bound to the nanoparticle (SSHEL)</li>\n<li>Use of SSHELs that display a therapeutic agent to treat a disease, e.g. Doxorubicin for HER2-positive cancer</li>\n<li>Use of SSHELs to deliver vaccines to patients</li>\n<li>Use of SSHELs to provide particles with enzymatic functions</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>The ability to display multiple types of therapeutic agents provides diversity of function</li>\n<li>The ability to vary the amount of SpoIVA that can bind to a functional agent (e.g. Doxorubicin through a streptavidin-biotin interaction) allows fine tuning, high targeting efficiency, and reduced toxicity</li>\n<li>Lack of extraneous cell surface proteins on SSHELs avoids potential interference between the SSHEL and its target</li>\n<li>Non-living delivery system avoids complications associated with using a living organism</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">David Lambertson</a><br /><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">david.lambertson@nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/127,738 <br />Filed on 2015-03-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Wu et al. A Versatile Nano-Display Platform from Bacterial Spore Coat Proteins<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25854653\">PMID: 25854653</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-03-23T12:00:00Z\" class=\"datetime\">2017-03-23</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-098-2015", "body": "<p>Bacterial spores can be modified to display molecules of interest, including drugs, immunogenic peptides, antibodies and other functional proteins of interest (such as enzymes).  The resulting engineered bacterial spores can provide many useful functions such as the treatment of infections, use as an adjuvant for the delivery of vaccines, and the enzymatic degradation of environmental pollutants.</p>\n<p>Researchers at the National Cancer Institute’s (NCI) <a href=\"https://ccr.cancer.gov/Laboratory-of-Molecular-Biology\" rel=\"nofollow\">Laboratory of Molecular Biology</a> have developed a novel, synthetic spore husk-encased lipid bilayer (SSHEL) particle that is uniquely suited for a variety of these functions. The assembly of SSHELs involves the insertion of the bacterial spore coat protein SpoVM into a lipid bilayer that is located on a synthetic core particle.  SpoVM serves as a structural element and recruitment factor for the bacterial spore coat protein SpoIVA.  When SpoIVA is conjugated to streptavidin, the SSHEL can bind to another molecule through a biotin linkage.  This leads to the creation of a specialized SSHEL that can serve a particular biological function.  The lab's pre-clinical work has demonstrated that SSHELs loaded with Doxorubicin reduced the tumor burden in a mouse tumor xenograft model of HER2-positive ovarian cancer.  By varying the ratio of streptavidin-conjugated and unconjugated SpoIVA protein used in the manufacture of the SSHEL, it is possible to tailor the amount of functional molecule that is present in the SSHEL.  This affords greater control over the level of activity that is provided by the SSHEL, thereby allowing the fine tuning of its function.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_collaboration_description": "Licensing and research collaboration", "field_collaborations": ["Licensing Desired", "Licensing & Collaboration Desired", "Collaboration Sought"], "field_commercial_applications": "<ul><li>Applications for this technology are only limited by the molecules bound to the nanoparticle (SSHEL)</li>\n<li>Use of SSHELs that display a therapeutic agent to treat a disease, e.g. Doxorubicin for HER2-positive cancer</li>\n<li>Use of SSHELs to deliver vaccines to patients</li>\n<li>Use of SSHELs to provide particles with enzymatic functions</li>\n</ul>", "field_competitive_advantages": "<ul><li>The ability to display multiple types of therapeutic agents provides diversity of function</li>\n<li>The ability to vary the amount of SpoIVA that can bind to a functional agent (e.g. Doxorubicin through a streptavidin-biotin interaction) allows fine tuning, high targeting efficiency, and reduced toxicity</li>\n<li>Lack of extraneous cell surface proteins on SSHELs avoids potential interference between the SSHEL and its target</li>\n<li>Non-living delivery system avoids complications associated with using a living organism</li>\n</ul>", "field_data_source": "nci", "field_data_source_id": "NCI-E-098-2015", "field_date_published": 1490270400, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-098-2015", "field_inventors": "Kumaran Ramamurthi (NCI)", "field_publications": "<div class='publication outer-container'><div class='publication inner-container'>Wu et al. A Versatile Nano-Display Platform from Bacterial Spore Coat Proteins<br><a href='https://www.ncbi.nlm.nih.gov/pubmed/25854653'>PMID: 25854653</a></div></div>", "nid": 786880, "status": true, "title": "Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/786880:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/786880:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Bacterial spores can be modified to display molecules of", "matchLevel": "none" }, "body": { "value": "Bacterial spores can be modified to display molecules of interest", "matchLevel": "none" }, "field_id": { "value": "NCI-E-098-2015", "matchLevel": "none" }, "title": { "value": "Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"786880\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Bacterial spores can be modified to display molecules of interest, including drugs, immunogenic peptides, antibodies and other functional proteins of interest (such as enzymes).  The resulting engineered bacterial spores can provide many useful functions such as the treatment of infections, use as an adjuvant for the delivery of vaccines, and the enzymatic degradation of environmental pollutants.</p>\n<p>Researchers at the National Cancer Institute’s (NCI) <a href=\"https://ccr.cancer.gov/Laboratory-of-Molecular-Biology\" rel=\"nofollow\">Laboratory of Molecular Biology</a> have developed a novel, synthetic spore husk-encased lipid bilayer (SSHEL) particle that is uniquely suited for a variety of these functions. The assembly of SSHELs involves the insertion of the bacterial spore coat protein SpoVM into a lipid bilayer that is located on a synthetic core particle.  SpoVM serves as a structural element and recruitment factor for the bacterial spore coat protein SpoIVA.  When SpoIVA is conjugated to streptavidin, the SSHEL can bind to another molecule through a biotin linkage.  This leads to the creation of a specialized SSHEL that can serve a particular biological function.  The lab's pre-clinical work has demonstrated that SSHELs loaded with Doxorubicin reduced the tumor burden in a mouse tumor xenograft model of HER2-positive ovarian cancer.  By varying the ratio of streptavidin-conjugated and unconjugated SpoIVA protein used in the manufacture of the SSHEL, it is possible to tailor the amount of functional molecule that is present in the SSHEL.  This affords greater control over the level of activity that is provided by the SSHEL, thereby allowing the fine tuning of its function.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Applications for this technology are only limited by the molecules bound to the nanoparticle (SSHEL)</li>\n<li>Use of SSHELs that display a therapeutic agent to treat a disease, e.g. Doxorubicin for HER2-positive cancer</li>\n<li>Use of SSHELs to deliver vaccines to patients</li>\n<li>Use of SSHELs to provide particles with enzymatic functions</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>The ability to display multiple types of therapeutic agents provides diversity of function</li>\n<li>The ability to vary the amount of SpoIVA that can bind to a functional agent (e.g. Doxorubicin through a streptavidin-biotin interaction) allows fine tuning, high targeting efficiency, and reduced toxicity</li>\n<li>Lack of extraneous cell surface proteins on SSHELs avoids potential interference between the SSHEL and its target</li>\n<li>Non-living delivery system avoids complications associated with using a living organism</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-098-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Kumaran Ramamurthi (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Discovery (Lead Identification)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">David Lambertson</a><br /><a href=\"mailto:david.lambertson@nih.gov?subject=Web Inquiry regarding [NCI-E-098-2015]\">david.lambertson@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/127,738 <br />Filed on 2015-03-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Wu et al. A Versatile Nano-Display Platform from Bacterial Spore Coat Proteins<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/25854653\">PMID: 25854653</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20&amp;Collaboration_Desired=\" hreflang=\"und\">Licensing &amp; Collaboration Desired</a></li>\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Collaboration%20Sought\" hreflang=\"und\">Collaboration Sought</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing and research collaboration</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2017-03-23T12:00:00Z\" class=\"datetime\">Thu, 03/23/2017 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Bacterial spores can be modified to display molecules of interest, including drugs, immunogenic peptides, antibodies and other functional proteins of interest (such as enzymes).  The resulting engineered bacterial spores can provide many useful functions such as the treatment of infections, use as an adjuvant for the delivery of vaccines, and the enzymatic degradation of environmental pollutants.</p>\n<p>Researchers at the National Cancer Institute’s (NCI) <a href=\"https://ccr.cancer.gov/Laboratory-of-Molecular-Biology\" rel=\"nofollow\">Laboratory of Molecular Biology</a> have developed a novel, synthetic spore husk-encased lipid bilayer (SSHEL) particle that is uniquely suited for a variety of these functions. The assembly of SSHELs involves the insertion of the bacterial spore coat protein SpoVM into a lipid bilayer that is located on a synthetic core particle.  SpoVM serves as a structural element and recruitment factor for the bacterial spore coat protein SpoIVA.  When SpoIVA is conjugated to streptavidin, the SSHEL can bind to another molecule through a biotin linkage.  This leads to the creation of a specialized SSHEL that can serve a particular biological function.  The lab's pre-clinical work has demonstrated that SSHELs loaded with Doxorubicin reduced the tumor burden in a mouse tumor xenograft model of HER2-positive ovarian cancer.  By varying the ratio of streptavidin-conjugated and unconjugated SpoIVA protein used in the manufacture of the SSHEL, it is possible to tailor the amount of functional molecule that is present in the SSHEL.  This affords greater control over the level of activity that is provided by the SSHEL, thereby allowing the fine tuning of its function.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-098-2015", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Synthetic Bacterial Nanoparticles as Drug and Vaccine Delivery Vehicles", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"786862\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissues samples collected during medical procedures, such as biopsies, are used to diagnose a wide variety of diseases. Before diagnosis, patient samples are typically processed by fixation and paraffin embedding. This fixation/embedding process is used to preserve tissue morphology and histology for subsequent evaluation. Unfortunately, most fixative agents can damage or destroy nucleic acids (RNA and DNA) and damage proteins during the fixation process, thereby potentially impairing diagnostic assessment of tissue.</p>\n<p>Researchers in the National Cancer Institute’s <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology</a> have developed an improved tissue fixative solution that is formaldehyde-free. This novel fixative, BE70, significantly improves DNA, RNA, and protein biomolecule integrity in histological samples compared to traditional fixatives. Additionally, BE70 is compatible with current protocols and does not alter tissue processing.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Improve integrity of fixed tissue samples</li>\n<li>Improve RNA/DNA quality in fixed tissue samples</li>\n<li>Non-cross linking, improved protein quality</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>There is substantial interest in new fixatives to replace neutral buffered formalin (a carcinogen) as primary fixative agent for surgical pathology</li>\n<li>BE70 overcomes several limitations of other fixatives, including cost and disposal issues</li>\n<li>Could be formulated as a concentrate, and marketed as an additive (to be added during dilution of ethanol)</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-139-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Candice Perry (Leidos)</div>\n          <div class=\"field__item\">Joon-Yong Chung (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/255,030 <br />Filed on 2015-11-13</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Perry C, et al. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications.<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27221702\">PMID 27221702</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-09-22T12:00:00Z\" class=\"datetime\">Thu, 09/22/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"786862\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-139-2015</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Candice Perry (Leidos)</div>\n          <div class=\"field__item\">Joon-Yong Chung (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissues samples collected during medical procedures, such as biopsies, are used to diagnose a wide variety of diseases. Before diagnosis, patient samples are typically processed by fixation and paraffin embedding. This fixation/embedding process is used to preserve tissue morphology and histology for subsequent evaluation. Unfortunately, most fixative agents can damage or destroy nucleic acids (RNA and DNA) and damage proteins during the fixation process, thereby potentially impairing diagnostic assessment of tissue.</p>\n<p>Researchers in the National Cancer Institute’s <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology</a> have developed an improved tissue fixative solution that is formaldehyde-free. This novel fixative, BE70, significantly improves DNA, RNA, and protein biomolecule integrity in histological samples compared to traditional fixatives. Additionally, BE70 is compatible with current protocols and does not alter tissue processing.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Improve integrity of fixed tissue samples</li>\n<li>Improve RNA/DNA quality in fixed tissue samples</li>\n<li>Non-cross linking, improved protein quality</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>There is substantial interest in new fixatives to replace neutral buffered formalin (a carcinogen) as primary fixative agent for surgical pathology</li>\n<li>BE70 overcomes several limitations of other fixatives, including cost and disposal issues</li>\n<li>Could be formulated as a concentrate, and marketed as an additive (to be added during dilution of ethanol)</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/255,030 <br />Filed on 2015-11-13</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Perry C, et al. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications.<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27221702\">PMID 27221702</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-09-22T12:00:00Z\" class=\"datetime\">2016-09-22</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-139-2015", "body": "<p>Tissues samples collected during medical procedures, such as biopsies, are used to diagnose a wide variety of diseases. Before diagnosis, patient samples are typically processed by fixation and paraffin embedding. This fixation/embedding process is used to preserve tissue morphology and histology for subsequent evaluation. Unfortunately, most fixative agents can damage or destroy nucleic acids (RNA and DNA) and damage proteins during the fixation process, thereby potentially impairing diagnostic assessment of tissue.</p>\n<p>Researchers in the National Cancer Institute’s <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology</a> have developed an improved tissue fixative solution that is formaldehyde-free. This novel fixative, BE70, significantly improves DNA, RNA, and protein biomolecule integrity in histological samples compared to traditional fixatives. Additionally, BE70 is compatible with current protocols and does not alter tissue processing.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_co_inventors": ["Candice Perry (Leidos)", "Joon-Yong Chung (NCI)"], "field_collaboration_description": "Licensing only", "field_collaborations": "Licensing Desired", "field_commercial_applications": "<ul><li>Improve integrity of fixed tissue samples</li>\n<li>Improve RNA/DNA quality in fixed tissue samples</li>\n<li>Non-cross linking, improved protein quality</li>\n</ul>", "field_competitive_advantages": "<ul><li>There is substantial interest in new fixatives to replace neutral buffered formalin (a carcinogen) as primary fixative agent for surgical pathology</li>\n<li>BE70 overcomes several limitations of other fixatives, including cost and disposal issues</li>\n<li>Could be formulated as a concentrate, and marketed as an additive (to be added during dilution of ethanol)</li>\n</ul>", "field_data_source": "nci", "field_data_source_id": "NCI-E-139-2015", "field_date_published": 1474545600, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-139-2015", "field_inventors": ["Candice Perry (Leidos)", "Joon-Yong Chung (NCI)", "Stephen Hewitt (NCI)"], "field_publications": "<div class='publication outer-container'><div class='publication inner-container'>Perry C, et al.&nbsp;A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications.<br><a href='https://www.ncbi.nlm.nih.gov/pubmed/27221702'>PMID 27221702</a></div></div>", "nid": 786862, "status": true, "title": "Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/786862:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/786862:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Tissues samples collected during medical procedures, such as biopsies", "matchLevel": "none" }, "body": { "value": "Tissues samples collected during medical procedures, such as biopsies, are", "matchLevel": "none" }, "field_id": { "value": "NCI-E-139-2015", "matchLevel": "none" }, "title": { "value": "Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"786862\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Tissues samples collected during medical procedures, such as biopsies, are used to diagnose a wide variety of diseases. Before diagnosis, patient samples are typically processed by fixation and paraffin embedding. This fixation/embedding process is used to preserve tissue morphology and histology for subsequent evaluation. Unfortunately, most fixative agents can damage or destroy nucleic acids (RNA and DNA) and damage proteins during the fixation process, thereby potentially impairing diagnostic assessment of tissue.</p>\n<p>Researchers in the National Cancer Institute’s <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology</a> have developed an improved tissue fixative solution that is formaldehyde-free. This novel fixative, BE70, significantly improves DNA, RNA, and protein biomolecule integrity in histological samples compared to traditional fixatives. Additionally, BE70 is compatible with current protocols and does not alter tissue processing.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Improve integrity of fixed tissue samples</li>\n<li>Improve RNA/DNA quality in fixed tissue samples</li>\n<li>Non-cross linking, improved protein quality</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>There is substantial interest in new fixatives to replace neutral buffered formalin (a carcinogen) as primary fixative agent for surgical pathology</li>\n<li>BE70 overcomes several limitations of other fixatives, including cost and disposal issues</li>\n<li>Could be formulated as a concentrate, and marketed as an additive (to be added during dilution of ethanol)</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-139-2015</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stephen Hewitt (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Candice Perry (Leidos)</div>\n          <div class=\"field__item\">Joon-Yong Chung (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">Jaime Greene</a><br /><a href=\"mailto:greenejaime@mail.nih.gov?subject=Web Inquiry regarding [NCI-E-139-2015]\">greenejaime@mail.nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">US Provisional Application 62/255,030 <br />Filed on 2015-11-13</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-publications field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Publications</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Perry C, et al. A Buffered Alcohol-Based Fixative for Histomorphologic and Molecular Applications.<br /><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27221702\">PMID 27221702</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-09-22T12:00:00Z\" class=\"datetime\">Thu, 09/22/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Tissues samples collected during medical procedures, such as biopsies, are used to diagnose a wide variety of diseases. Before diagnosis, patient samples are typically processed by fixation and paraffin embedding. This fixation/embedding process is used to preserve tissue morphology and histology for subsequent evaluation. Unfortunately, most fixative agents can damage or destroy nucleic acids (RNA and DNA) and damage proteins during the fixation process, thereby potentially impairing diagnostic assessment of tissue.</p>\n<p>Researchers in the National Cancer Institute’s <a href=\"https://ccr.cancer.gov/Laboratory-of-Pathology\" rel=\"nofollow\">Laboratory of Pathology</a> have developed an improved tissue fixative solution that is formaldehyde-free. This novel fixative, BE70, significantly improves DNA, RNA, and protein biomolecule integrity in histological samples compared to traditional fixatives. Additionally, BE70 is compatible with current protocols and does not alter tissue processing.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-139-2015", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Novel Fixative for Improved Biomolecule Quality from Paraffin-Embedded Tissue", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"786692\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology for delivering proteins into cells by exploiting the ability of certain proteins to penetrate the cell membrane.  However, the majority of the proteins delivered by this means are usually trapped and subsequently degraded in the endosomes-lysosomes of recipient cells. </p>\n<p>\tThis invention describes a method for the delivery of proteins into cells using virus-like particles (VLPs) either in a non-targeted or a targeted way. VLPs are structures resembling a virus particle capable of self-assembly into nanoparticles, but are non-replicating because they lack viral nucleic acids.  The technology is based on fusion of protein(s) of interest with GAG structural protein of Rous Sarcoma Virus (RSV) pseudotyped with VSV-G (glycoprotein envelope) or its mutant form for targeted delivery.   In addition, a chimeric VLP could be used to deliver functional fusion proteins or fully-processed proteins (protease) into the cytoplasm or nucleus of target cells.  Since the problem of endosomal entrapment is eliminated, proteins can be delivered to target cells more efficiently than existing protein transduction methods.  Contrary to retroviral-mediated gene delivery, no genetic retroviral material is incorporated into VLP. This allows for safe protein delivery and eliminates unsafe incorporation of retroviral DNA into the host chromosome.</p>\n<p>\tThe inventors have validated the biological activity of Cre recombinase and cytotoxic enzymes delivered using VLPs in a human prostate cancer cell line.  Specific ligands such as TNF-related apoptosis-inducing ligand (TRAIL) can be displayed on the surface of hybrid VLPs.  In vitro assays indicated that VLP-mediated TRAIL delivery is at least twice as effective and required 1000 times less peptide than soluble TRAIL, which is currently under clinical trial elsewhere.     </p>\n<p>\tIn addition to protein therapy that might be used to treat numerous diseases and disorders, this technology can also be used for expansion of stem cells for transplantation as well as for the development of cancer vaccines.    </p>\n<p>\tFurther R&amp;D Needed:</p>\n<ul><li>In vivo studies on mouse models</li>\n<li>Capability of conducting in vivo studies in larger animals is desired.</li>\n<li>Collaborations regarding any aspect of the VLP-delivery platform technology will be considered</li>\n</ul><p>R&amp;D Status: Pre-clinical in-vitro proof of concept with human prostate cancer cell lines indicated VLP-mediated TRAIL delivery is at least twice as effective and requires 1000 times less peptide than soluble TRAIL.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Intracellular targeted delivery of therapeutic proteins.</li>\n<li>Ex vivo use for expansion of stem cells for transplantation.</li>\n<li>Antigen loading of dendritic cells for cancer vaccination.</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Platform technology that could be applied to the targeted killing of tumors, protein therapy, stem cell generation, and cancer vaccine development</li>\n<li>Transformations of VLPs permits targeting of specific receptors on cells</li>\n<li>Proteins are not trapped and degraded in the endosomes/lysosomes of target cells.</li>\n<li>Lack of genetic retroviral materials in VLP allows safe protein delivery and eliminates potentially unsafe incorporation of retroviral DNA into host chromosome.</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Method for Targeted Therapeutic Delivery of Proteins into Cells\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-010-2008</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stanislaw Kaczmarczyk (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Deb Chatterjee (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">Lauren Nguyen-Antczak</a><br /><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">lauren.nguyen-antczak@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">U.S. Application 61/195,084 <br />Filed on 2008-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-08-24T12:00:00Z\" class=\"datetime\">Wed, 08/24/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"786692\" class=\"node node--type-technology-bundle node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-010-2008</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Method for Targeted Therapeutic Delivery of Proteins into Cells\n</h1>\n</div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-bookmark-technology field--type-ds field--label-hidden field__item\"><div class=\"bookmark page\" data-category=\"bookmark\" title=\"Add Bookmark\"></div></div>\n      \n            <div class=\"field field--name-dynamic-twig-fieldnode-history-technology field--type-ds field--label-hidden field__item\"><div class=\"history page\" data-category=\"history\" title=\"Log History\"></div></div>\n      \n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stanislaw Kaczmarczyk (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Deb Chatterjee (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology for delivering proteins into cells by exploiting the ability of certain proteins to penetrate the cell membrane.  However, the majority of the proteins delivered by this means are usually trapped and subsequently degraded in the endosomes-lysosomes of recipient cells. </p>\n<p>\tThis invention describes a method for the delivery of proteins into cells using virus-like particles (VLPs) either in a non-targeted or a targeted way. VLPs are structures resembling a virus particle capable of self-assembly into nanoparticles, but are non-replicating because they lack viral nucleic acids.  The technology is based on fusion of protein(s) of interest with GAG structural protein of Rous Sarcoma Virus (RSV) pseudotyped with VSV-G (glycoprotein envelope) or its mutant form for targeted delivery.   In addition, a chimeric VLP could be used to deliver functional fusion proteins or fully-processed proteins (protease) into the cytoplasm or nucleus of target cells.  Since the problem of endosomal entrapment is eliminated, proteins can be delivered to target cells more efficiently than existing protein transduction methods.  Contrary to retroviral-mediated gene delivery, no genetic retroviral material is incorporated into VLP. This allows for safe protein delivery and eliminates unsafe incorporation of retroviral DNA into the host chromosome.</p>\n<p>\tThe inventors have validated the biological activity of Cre recombinase and cytotoxic enzymes delivered using VLPs in a human prostate cancer cell line.  Specific ligands such as TNF-related apoptosis-inducing ligand (TRAIL) can be displayed on the surface of hybrid VLPs.  In vitro assays indicated that VLP-mediated TRAIL delivery is at least twice as effective and required 1000 times less peptide than soluble TRAIL, which is currently under clinical trial elsewhere.     </p>\n<p>\tIn addition to protein therapy that might be used to treat numerous diseases and disorders, this technology can also be used for expansion of stem cells for transplantation as well as for the development of cancer vaccines.    </p>\n<p>\tFurther R&amp;D Needed:</p>\n<ul><li>In vivo studies on mouse models</li>\n<li>Capability of conducting in vivo studies in larger animals is desired.</li>\n<li>Collaborations regarding any aspect of the VLP-delivery platform technology will be considered</li>\n</ul><p>R&amp;D Status: Pre-clinical in-vitro proof of concept with human prostate cancer cell lines indicated VLP-mediated TRAIL delivery is at least twice as effective and requires 1000 times less peptide than soluble TRAIL.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Intracellular targeted delivery of therapeutic proteins.</li>\n<li>Ex vivo use for expansion of stem cells for transplantation.</li>\n<li>Antigen loading of dendritic cells for cancer vaccination.</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Platform technology that could be applied to the targeted killing of tumors, protein therapy, stem cell generation, and cancer vaccine development</li>\n<li>Transformations of VLPs permits targeting of specific receptors on cells</li>\n<li>Proteins are not trapped and degraded in the endosomes/lysosomes of target cells.</li>\n<li>Lack of genetic retroviral materials in VLP allows safe protein delivery and eliminates potentially unsafe incorporation of retroviral DNA into host chromosome.</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">Lauren Nguyen-Antczak</a><br /><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">lauren.nguyen-antczak@nih.gov</a><br /></div>\n          </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">U.S. Application 61/195,084 <br />Filed on 2008-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-08-24T12:00:00Z\" class=\"datetime\">2016-08-24</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/bundle/nci-e-010-2008", "body": "<p>Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology for delivering proteins into cells by exploiting the ability of certain proteins to penetrate the cell membrane.  However, the majority of the proteins delivered by this means are usually trapped and subsequently degraded in the endosomes-lysosomes of recipient cells. </p>\n<p>\tThis invention describes a method for the delivery of proteins into cells using virus-like particles (VLPs) either in a non-targeted or a targeted way. VLPs are structures resembling a virus particle capable of self-assembly into nanoparticles, but are non-replicating because they lack viral nucleic acids.  The technology is based on fusion of protein(s) of interest with GAG structural protein of Rous Sarcoma Virus (RSV) pseudotyped with VSV-G (glycoprotein envelope) or its mutant form for targeted delivery.   In addition, a chimeric VLP could be used to deliver functional fusion proteins or fully-processed proteins (protease) into the cytoplasm or nucleus of target cells.  Since the problem of endosomal entrapment is eliminated, proteins can be delivered to target cells more efficiently than existing protein transduction methods.  Contrary to retroviral-mediated gene delivery, no genetic retroviral material is incorporated into VLP. This allows for safe protein delivery and eliminates unsafe incorporation of retroviral DNA into the host chromosome.</p>\n<p>\tThe inventors have validated the biological activity of Cre recombinase and cytotoxic enzymes delivered using VLPs in a human prostate cancer cell line.  Specific ligands such as TNF-related apoptosis-inducing ligand (TRAIL) can be displayed on the surface of hybrid VLPs.  In vitro assays indicated that VLP-mediated TRAIL delivery is at least twice as effective and required 1000 times less peptide than soluble TRAIL, which is currently under clinical trial elsewhere.     </p>\n<p>\tIn addition to protein therapy that might be used to treat numerous diseases and disorders, this technology can also be used for expansion of stem cells for transplantation as well as for the development of cancer vaccines.    </p>\n<p>\tFurther R&amp;D Needed:</p>\n<ul><li>In vivo studies on mouse models</li>\n<li>Capability of conducting in vivo studies in larger animals is desired.</li>\n<li>Collaborations regarding any aspect of the VLP-delivery platform technology will be considered</li>\n</ul><p>R&amp;D Status: Pre-clinical in-vitro proof of concept with human prostate cancer cell lines indicated VLP-mediated TRAIL delivery is at least twice as effective and requires 1000 times less peptide than soluble TRAIL.</p>", "field_applications": ["Non-Medical Devices", "Medical Devices"], "field_co_inventors": "Deb Chatterjee (NCI)", "field_collaboration_description": "Licensing only", "field_collaborations": "Licensing Desired", "field_commercial_applications": "<ul><li>Intracellular targeted delivery of therapeutic proteins.</li>\n<li>Ex vivo use for expansion of stem cells for transplantation.</li>\n<li>Antigen loading of dendritic cells for cancer vaccination.</li>\n</ul>", "field_competitive_advantages": "<ul><li>Platform technology that could be applied to the targeted killing of tumors, protein therapy, stem cell generation, and cancer vaccine development</li>\n<li>Transformations of VLPs permits targeting of specific receptors on cells</li>\n<li>Proteins are not trapped and degraded in the endosomes/lysosomes of target cells.</li>\n<li>Lack of genetic retroviral materials in VLP allows safe protein delivery and eliminates potentially unsafe incorporation of retroviral DNA into host chromosome.</li>\n</ul>", "field_data_source": "nci", "field_data_source_id": "NCI-E-010-2008", "field_date_published": 1472040000, "field_ics": "NCI", "field_ics_id": 189, "field_id": "NCI-E-010-2008", "field_inventors": ["Deb Chatterjee (NCI)", "Stanislaw Kaczmarczyk (NCI)"], "nid": 786692, "status": true, "title": "Method for Targeted Therapeutic Delivery of Proteins into Cells", "type": "technology_bundle", "uid": 1, "search_api_id": "entity:node/786692:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/786692:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            Current methods to deliver proteins into cells (e.g", "matchLevel": "none" }, "body": { "value": "Current methods to deliver proteins into cells (e.g., using", "matchLevel": "none" }, "field_id": { "value": "NCI-E-010-2008", "matchLevel": "none" }, "title": { "value": "Method for Targeted Therapeutic Delivery of Proteins into Cells", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"786692\" class=\"node node--type-technology-bundle node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\"><p>Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology for delivering proteins into cells by exploiting the ability of certain proteins to penetrate the cell membrane.  However, the majority of the proteins delivered by this means are usually trapped and subsequently degraded in the endosomes-lysosomes of recipient cells. </p>\n<p>\tThis invention describes a method for the delivery of proteins into cells using virus-like particles (VLPs) either in a non-targeted or a targeted way. VLPs are structures resembling a virus particle capable of self-assembly into nanoparticles, but are non-replicating because they lack viral nucleic acids.  The technology is based on fusion of protein(s) of interest with GAG structural protein of Rous Sarcoma Virus (RSV) pseudotyped with VSV-G (glycoprotein envelope) or its mutant form for targeted delivery.   In addition, a chimeric VLP could be used to deliver functional fusion proteins or fully-processed proteins (protease) into the cytoplasm or nucleus of target cells.  Since the problem of endosomal entrapment is eliminated, proteins can be delivered to target cells more efficiently than existing protein transduction methods.  Contrary to retroviral-mediated gene delivery, no genetic retroviral material is incorporated into VLP. This allows for safe protein delivery and eliminates unsafe incorporation of retroviral DNA into the host chromosome.</p>\n<p>\tThe inventors have validated the biological activity of Cre recombinase and cytotoxic enzymes delivered using VLPs in a human prostate cancer cell line.  Specific ligands such as TNF-related apoptosis-inducing ligand (TRAIL) can be displayed on the surface of hybrid VLPs.  In vitro assays indicated that VLP-mediated TRAIL delivery is at least twice as effective and required 1000 times less peptide than soluble TRAIL, which is currently under clinical trial elsewhere.     </p>\n<p>\tIn addition to protein therapy that might be used to treat numerous diseases and disorders, this technology can also be used for expansion of stem cells for transplantation as well as for the development of cancer vaccines.    </p>\n<p>\tFurther R&amp;D Needed:</p>\n<ul><li>In vivo studies on mouse models</li>\n<li>Capability of conducting in vivo studies in larger animals is desired.</li>\n<li>Collaborations regarding any aspect of the VLP-delivery platform technology will be considered</li>\n</ul><p>R&amp;D Status: Pre-clinical in-vitro proof of concept with human prostate cancer cell lines indicated VLP-mediated TRAIL delivery is at least twice as effective and requires 1000 times less peptide than soluble TRAIL.</p></div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Intracellular targeted delivery of therapeutic proteins.</li>\n<li>Ex vivo use for expansion of stem cells for transplantation.</li>\n<li>Antigen loading of dendritic cells for cancer vaccination.</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Platform technology that could be applied to the targeted killing of tumors, protein therapy, stem cell generation, and cancer vaccine development</li>\n<li>Transformations of VLPs permits targeting of specific receptors on cells</li>\n<li>Proteins are not trapped and degraded in the endosomes/lysosomes of target cells.</li>\n<li>Lack of genetic retroviral materials in VLP allows safe protein delivery and eliminates potentially unsafe incorporation of retroviral DNA into host chromosome.</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Non-Medical%20Devices\" hreflang=\"und\">Non-Medical Devices</a></div>\n          <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_applications%5D%5B0%5D=Medical%20Devices\" hreflang=\"und\">Medical Devices</a></div>\n              </div>\n      </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Method for Targeted Therapeutic Delivery of Proteins into Cells\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology Bundle ID</div>\n              <div class=\"field__item\">NCI-E-010-2008</div>\n          </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Stanislaw Kaczmarczyk (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Deb Chatterjee (NCI)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">Pre-clinical (in vivo)</div>\n          </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_ics%5D%5B0%5D=NCI\" hreflang=\"und\">NCI</a></div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contact field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contact:</div>\n              <div class=\"field__item\"><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">Lauren Nguyen-Antczak</a><br /><a href=\"mailto:lauren.nguyen-antczak@nih.gov?subject=Web Inquiry regarding [NCI-E-010-2008]\">lauren.nguyen-antczak@nih.gov</a><br /></div>\n          </div>\n\n\n  <div class=\"field field--name-field-intellectual-properties field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Intellectual Properties</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">U.S. Application 61/195,084 <br />Filed on 2008-10-03</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\"><a href=\"/node/9190?ottdev%5BrefinementList%5D%5Bfield_collaborations%5D%5B0%5D=Licensing%20Desired\" hreflang=\"und\">Licensing Desired</a></li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Licensing only</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-08-24T12:00:00Z\" class=\"datetime\">Wed, 08/24/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "<p>Current methods to deliver proteins into cells (e.g., using retrovirus, DNA transfection, protein transduction, microinjection, complexing the protein with lipids, etc.) have many shortcomings, such as lack of target specificity toxicity, or unwanted random integration into the host chromosome.  Protein transduction is an emerging technology for delivering proteins into cells by exploiting the ability of certain proteins to penetrate the cell membrane.  However, the majority of the proteins delivered by this means are usually trapped and subsequently degraded in the endosomes-lysosomes of recipient cells. </p>\n<p>\tThis invention describes a method for the delivery of proteins into cells using virus-like particles (VLPs) either in a non-targeted or a targeted way. VLPs are structures resembling a virus particle capable of self-assembly into nanoparticles, but are non-replicating because they lack viral nucleic acids.  The technology is based on fusion of protein(s) of interest with GAG structural protein of Rous Sarcoma Virus (RSV) pseudotyped with VSV-G (glycoprotein envelope) or its mutant form for targeted delivery.   In addition, a chimeric VLP could be used to deliver functional fusion proteins or fully-processed proteins (protease) into the cytoplasm or nucleus of target cells.  Since the problem of endosomal entrapment is eliminated, proteins can be delivered to target cells more efficiently than existing protein transduction methods.  Contrary to retroviral-mediated gene delivery, no genetic retroviral material is incorporated into VLP. This allows for safe protein delivery and eliminates unsafe incorporation of retroviral DNA into the host chromosome.</p>\n<p>\tThe inventors have validated the biological activity of Cre recombinase and cytotoxic enzymes delivered using VLPs in a human prostate cancer cell line.  Specific ligands such as TNF-related apoptosis-inducing ligand (TRAIL) can be displayed on the surface of hybrid VLPs.  In vitro assays indicated that VLP-mediated TRAIL delivery is at least twice as effective and required 1000 times less peptide than soluble TRAIL, which is currently under clinical trial elsewhere.     </p>\n<p>\tIn addition to protein therapy that might be used to treat numerous diseases and disorders, this technology can also be used for expansion of stem cells for transplantation as well as for the development of cancer vaccines.    </p>\n<p>\tFurther R&amp;D Needed:</p>\n<ul><li>In vivo studies on mouse models</li>\n<li>Capability of conducting in vivo studies in larger animals is desired.</li>\n<li>Collaborations regarding any aspect of the VLP-delivery platform technology will be considered</li>\n</ul><p>R&amp;D Status: Pre-clinical in-vitro proof of concept with human prostate cancer cell lines indicated VLP-mediated TRAIL delivery is at least twice as effective and requires 1000 times less peptide than soluble TRAIL.</p>", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "NCI-E-010-2008", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Method for Targeted Therapeutic Delivery of Proteins into Cells", "matchLevel": "none", "matchedWords": [] } } },
		{ "entity_type": "node", "rendered_item": "<div data-history-node-id=\"785617\" class=\"therapeutics software---apps research-materials non-medical-devices medical-devices diagnostics consumer-products node node--type-tech node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\">The invention relates to fluorescent nanodiamonds (FNDs) and their uses as fiducial markers for microscopy.  FNDs are bright fluorescent probes that do not blink or bleach and have broad fluorescence excitation and emission peaks.  The fluorescence intensity can be readily controlled by the size of the FND, the number of fluorescent centers produced in the nanodiamonds, or in situ through the application of a weak magnetic field.  The particular advantage of the FND compositions of this invention are that they are particularly useful for extended imaging of a single sample over time periods that can be as long as a week or more. In an exemplary embodiment, FNDs are immobilized in a substrate that are coated with an inert top coating, like silicon dioxide, or transparent polymer (e.g. poly-L-lysine, poly-L-arginine, or siloxanes).  Generally, any suitable methods known for surface functionalization of the substrate can be used to make the composition.  In another aspect of this invention, the inventors designed software for super-resolution imaging correction method is employed to precisely determine the position coordinates of each of a set of FNDs in a plurality of images by using Gaussian fitting of the point spread function comprises each of the FNDs in the plurality of images.  The calculated correction is then used to displace each image to align the coordinates of the FNDs.  The positions of the FNDs can be tracked with sub-nanometer precision and residual drift can be reduced to the nanometer scale over hundreds of hours of tracking.</div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Fluorescent Microscopy</li>\n<li>Super-resolution microscopy</li>\n<li>Correlative imaging techniques combing fluorescence microscopy with electron, x-ray, or atomic force microscopy imaging modalities</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Non-blinking, Non-bleaching</li>\n<li>Chemically inert</li>\n<li>Chemically and physically stable</li>\n<li>Broad excitation</li>\n<li>Longevity</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology ID</div>\n              <div class=\"field__item\">TAB-2998</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Fluorescent Nanodiamonds as Fiducial Markers for Microscopy\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-e-numbers field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">E-Numbers</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">E-217-2015-0</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Neuman, Keir (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Samelson, Lawrence (NCI)</div>\n          <div class=\"field__item\">Manna, Asit (NCI)</div>\n          <div class=\"field__item\">Wen, Han (NHLBI)</div>\n          <div class=\"field__item\">Hong, Jennifer (NHLBI)</div>\n          <div class=\"field__item\">Yi, Chang (NCI)</div>\n          <div class=\"field__item\">Bumb, Ambika (Bikanta Corporation)</div>\n          <div class=\"field__item\">Sarkar, Susanta (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-development-stages field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Development Stages</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Pre-Clinical (in vitro)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-above\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">In vitro data available</div>\n          </div>\n\n  <div class=\"field field--name-field-research-products field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Research Products</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Research Equipment</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">NHLBI</div>\n          <div class=\"field__item\">NCI</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-organizations field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Organizations</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">NHLBI</div>\n          <div class=\"field__item\">NCI - CCR</div>\n          <div class=\"field__item\">Bikanta Corporation</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contacts field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contacts</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"mailto:\">Specialist (ALS), Admin. Licensing</a><br /><a href=\"mailto:\"></a><br />Phone: None</div>\n              </div>\n      </div>\n\n\n  <div class=\"field field--name-field-patents field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Patents</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Patent Cooperation Treaty<br />PCT/US2016/064523<br />Filed on 2016-12-02</li>\n              <li class=\"container-card--shadow\">US Application 62/262,058<br />Filed on 2015-12-02</li>\n              <li class=\"container-card--shadow\">US Application 15/780,388<br />Filed on 2018-05-31</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Collaboration</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">The National Heart, Lung and Blood Institute seeks statements of capability or interest from parties interested in collaborative research to further develop and evaluate metallic nanoparticle vesicles for cancer phototherapy. For collaboration opportunities, please contact Vincent Kolesnitchenko, Ph.D. at <a href=\"mailto:kolesniv@nhlbi.nih.gov\">kolesniv@nhlbi.nih.gov</a>.</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-01-11T12:00:00Z\" class=\"datetime\">Mon, 01/11/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "rendered_item_embed": "\n\n\n<div data-history-node-id=\"785617\" class=\"node node--type-tech node--view-mode-embed ds-2col-stacked-fluid clearfix background-tertiary content-top-gutter\">\n\n\n\n<div class=\"group-header content-left-right-gutters\">\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology ID</div>\n              <div class=\"field__item\">TAB-2998</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Fluorescent Nanodiamonds as Fiducial Markers for Microscopy\n</h1>\n</div>\n      \n</div>\n\n  <div class=\"group-middle content-left-right-gutters content-bottom-gutter clearfix\">\n\n      <div class=\"group-left\">\n\n    \n  <div class=\"field field--name-field-e-numbers field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">E-Numbers</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">E-217-2015-0</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Neuman, Keir (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Samelson, Lawrence (NCI)</div>\n          <div class=\"field__item\">Manna, Asit (NCI)</div>\n          <div class=\"field__item\">Wen, Han (NHLBI)</div>\n          <div class=\"field__item\">Hong, Jennifer (NHLBI)</div>\n          <div class=\"field__item\">Yi, Chang (NCI)</div>\n          <div class=\"field__item\">Bumb, Ambika (Bikanta Corporation)</div>\n          <div class=\"field__item\">Sarkar, Susanta (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-applications field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Applications</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Therapeutics</div>\n          <div class=\"field__item\">Software / Apps</div>\n          <div class=\"field__item\">Research Materials</div>\n          <div class=\"field__item\">Non-Medical Devices</div>\n          <div class=\"field__item\">Medical Devices</div>\n          <div class=\"field__item\">Diagnostics</div>\n          <div class=\"field__item\">Consumer Products</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-development-stages field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Development Stages</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Pre-Clinical (in vitro)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-inline\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">In vitro data available</div>\n          </div>\n\n  <div class=\"field field--name-field-research-products field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Research Products</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Research Equipment</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">NHLBI</div>\n          <div class=\"field__item\">NCI</div>\n              </div>\n      </div>\n\n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\">The invention relates to fluorescent nanodiamonds (FNDs) and their uses as fiducial markers for microscopy.  FNDs are bright fluorescent probes that do not blink or bleach and have broad fluorescence excitation and emission peaks.  The fluorescence intensity can be readily controlled by the size of the FND, the number of fluorescent centers produced in the nanodiamonds, or in situ through the application of a weak magnetic field.  The particular advantage of the FND compositions of this invention are that they are particularly useful for extended imaging of a single sample over time periods that can be as long as a week or more. In an exemplary embodiment, FNDs are immobilized in a substrate that are coated with an inert top coating, like silicon dioxide, or transparent polymer (e.g. poly-L-lysine, poly-L-arginine, or siloxanes).  Generally, any suitable methods known for surface functionalization of the substrate can be used to make the composition.  In another aspect of this invention, the inventors designed software for super-resolution imaging correction method is employed to precisely determine the position coordinates of each of a set of FNDs in a plurality of images by using Gaussian fitting of the point spread function comprises each of the FNDs in the plurality of images.  The calculated correction is then used to displace each image to align the coordinates of the FNDs.  The positions of the FNDs can be tracked with sub-nanometer precision and residual drift can be reduced to the nanometer scale over hundreds of hours of tracking.</div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Fluorescent Microscopy</li>\n<li>Super-resolution microscopy</li>\n<li>Correlative imaging techniques combing fluorescence microscopy with electron, x-ray, or atomic force microscopy imaging modalities</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Non-blinking, Non-bleaching</li>\n<li>Chemically inert</li>\n<li>Chemically and physically stable</li>\n<li>Broad excitation</li>\n<li>Longevity</li>\n</ul></div>\n          </div>\n\n    </div>\n  \n      <div class=\"group-right\">\n    <h2 class=\"heading-faux-button__blue\">Request More Info</h2>\n    \n  <div class=\"clearfix text-formatted field field--name-field-licensing-contacts field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contacts</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"mailto:\">Specialist (ALS), Admin. Licensing</a><br /><a href=\"mailto:\"></a><br />Phone: None</div>\n              </div>\n      </div>\n\n    </div>\n      </div>\n        <div class=\"group-footer-wrapper clearfix\">\n  \n    <div class=\"group-footer content-left-right-gutters\">\n    \n\n  <div class=\"field field--name-field-patents field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Patents</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Patent Cooperation Treaty<br />PCT/US2016/064523<br />Filed on 2016-12-02</li>\n              <li class=\"container-card--shadow\">US Application 62/262,058<br />Filed on 2015-12-02</li>\n              <li class=\"container-card--shadow\">US Application 15/780,388<br />Filed on 2018-05-31</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Collaboration</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">The National Heart, Lung and Blood Institute seeks statements of capability or interest from parties interested in collaborative research to further develop and evaluate metallic nanoparticle vesicles for cancer phototherapy. For collaboration opportunities, please contact Vincent Kolesnitchenko, Ph.D. at <a href=\"mailto:kolesniv@nhlbi.nih.gov\">kolesniv@nhlbi.nih.gov</a>.</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-01-11T12:00:00Z\" class=\"datetime\">Mon, 01/11/2016 - 12:00</time>\n</div>\n          </div>\n\n    </div>\n\n      </div>\n  \n\n</div>\n\n", "url": "http://default/tech/tab-2998", "body": "The invention relates to fluorescent nanodiamonds (FNDs) and their uses as fiducial markers for microscopy.  FNDs are bright fluorescent probes that do not blink or bleach and have broad fluorescence excitation and emission peaks.  The fluorescence intensity can be readily controlled by the size of the FND, the number of fluorescent centers produced in the nanodiamonds, or in situ through the application of a weak magnetic field.  The particular advantage of the FND compositions of this invention are that they are particularly useful for extended imaging of a single sample over time periods that can be as long as a week or more. In an exemplary embodiment, FNDs are immobilized in a substrate that are coated with an inert top coating, like silicon dioxide, or transparent polymer (e.g. poly-L-lysine, poly-L-arginine, or siloxanes).  Generally, any suitable methods known for surface functionalization of the substrate can be used to make the composition.  In another aspect of this invention, the inventors designed software for super-resolution imaging correction method is employed to precisely determine the position coordinates of each of a set of FNDs in a plurality of images by using Gaussian fitting of the point spread function comprises each of the FNDs in the plurality of images.  The calculated correction is then used to displace each image to align the coordinates of the FNDs.  The positions of the FNDs can be tracked with sub-nanometer precision and residual drift can be reduced to the nanometer scale over hundreds of hours of tracking.", "field_applications": ["Therapeutics", "Software / Apps", "Research Materials", "Non-Medical Devices", "Medical Devices", "Diagnostics", "Consumer Products"], "field_co_inventors": ["Samelson, Lawrence (NCI)", "Manna, Asit (NCI)", "Wen, Han (NHLBI)", "Hong, Jennifer (NHLBI)", "Yi, Chang (NCI)", "Bumb, Ambika (Bikanta Corporation)", "Sarkar, Susanta (NHLBI)"], "field_collaboration_description": "The National Heart, Lung and Blood Institute seeks statements of capability or interest from parties interested in collaborative research to further develop and evaluate metallic nanoparticle vesicles for cancer phototherapy. For collaboration opportunities, please contact Vincent Kolesnitchenko, Ph.D. at <a href=\"mailto:kolesniv@nhlbi.nih.gov\">kolesniv@nhlbi.nih.gov</a>.", "field_collaborations": "Collaboration", "field_commercial_applications": "<ul>\n<li>Fluorescent Microscopy</li>\n<li>Super-resolution microscopy</li>\n<li>Correlative imaging techniques combing fluorescence microscopy with electron, x-ray, or atomic force microscopy imaging modalities</li>\n</ul>", "field_competitive_advantages": "<ul>\n<li>Non-blinking, Non-bleaching</li>\n<li>Chemically inert</li>\n<li>Chemically and physically stable</li>\n<li>Broad excitation</li>\n<li>Longevity</li>\n</ul>", "field_data_source": "ett", "field_data_source_id": "TAB-2998", "field_date_published": 1452513600, "field_development_stages": "Pre-Clinical (in vitro)", "field_e_numbers": "E-217-2015-0", "field_govdelivery": false, "field_ics": ["NHLBI", "NCI"], "field_ics_id": [192, 189], "field_id": "TAB-2998", "field_inventors": ["Samelson, Lawrence (NCI)", "Manna, Asit (NCI)", "Neuman, Keir (NHLBI)", "Wen, Han (NHLBI)", "Hong, Jennifer (NHLBI)", "Yi, Chang (NCI)", "Bumb, Ambika (Bikanta Corporation)", "Sarkar, Susanta (NHLBI)"], "field_keywords": ["AC2XXX", "AC3XXX", "AC4XXX", "FIDUCIAL", "Fluorescence", "fluorescent", "IMAGING", "MICROSCOPY", "Nanodiamonds", "nanotechnology", "PXXXXX", "WIXXXX", "XFXXXX", "XGXXXX", "XHXXXX", "YBXXXX"], "field_licensing_contacts": "<a href=\"mailto:\">Specialist (ALS), Admin. Licensing</a><br><a href=\"mailto:\"></a><br>Phone: None", "field_organizations": ["NHLBI", "NCI - CCR", "Bikanta Corporation"], "field_organizations_id": [31485, 31498, 31499], "field_patents": ["Patent Cooperation Treaty<br />PCT/US2016/064523<br>Filed on 2016-12-02", "US Application 62/262,058<br>Filed on 2015-12-02", "US Application 15/780,388<br>Filed on 2018-05-31"], "field_research_products": "Research Equipment", "field_research_products_id": 255, "nid": 785617, "status": true, "title": "Fluorescent Nanodiamonds as Fiducial Markers for Microscopy", "type": "tech", "uid": 1, "search_api_id": "entity:node/785617:en", "search_api_datasource": "entity:node", "search_api_language": "en", "objectID": "entity:node/785617:en", "_snippetResult": { "rendered_item": { "value": "\n\n  \n\n  \n            The invention relates to fluorescent nanodiamonds (FNDs) and their", "matchLevel": "none" }, "body": { "value": "The invention relates to fluorescent nanodiamonds (FNDs) and their uses", "matchLevel": "none" }, "field_id": { "value": "TAB-2998", "matchLevel": "none" }, "title": { "value": "Fluorescent Nanodiamonds as Fiducial Markers for Microscopy", "matchLevel": "none" } }, "_highlightResult": { "rendered_item": { "value": "<div data-history-node-id=\"785617\" class=\"therapeutics software---apps research-materials non-medical-devices medical-devices diagnostics consumer-products node node--type-tech node--view-mode-search-index ds-1col clearfix\">\n\n  \n\n  \n            <div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item\">The invention relates to fluorescent nanodiamonds (FNDs) and their uses as fiducial markers for microscopy.  FNDs are bright fluorescent probes that do not blink or bleach and have broad fluorescence excitation and emission peaks.  The fluorescence intensity can be readily controlled by the size of the FND, the number of fluorescent centers produced in the nanodiamonds, or in situ through the application of a weak magnetic field.  The particular advantage of the FND compositions of this invention are that they are particularly useful for extended imaging of a single sample over time periods that can be as long as a week or more. In an exemplary embodiment, FNDs are immobilized in a substrate that are coated with an inert top coating, like silicon dioxide, or transparent polymer (e.g. poly-L-lysine, poly-L-arginine, or siloxanes).  Generally, any suitable methods known for surface functionalization of the substrate can be used to make the composition.  In another aspect of this invention, the inventors designed software for super-resolution imaging correction method is employed to precisely determine the position coordinates of each of a set of FNDs in a plurality of images by using Gaussian fitting of the point spread function comprises each of the FNDs in the plurality of images.  The calculated correction is then used to displace each image to align the coordinates of the FNDs.  The positions of the FNDs can be tracked with sub-nanometer precision and residual drift can be reduced to the nanometer scale over hundreds of hours of tracking.</div>\n      \n  <div class=\"clearfix text-formatted field field--name-field-commercial-applications field--type-text-long field--label-above\">\n    <div class=\"field__label\">Commercial Applications</div>\n              <div class=\"field__item\"><ul><li>Fluorescent Microscopy</li>\n<li>Super-resolution microscopy</li>\n<li>Correlative imaging techniques combing fluorescence microscopy with electron, x-ray, or atomic force microscopy imaging modalities</li>\n</ul></div>\n          </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-competitive-advantages field--type-text-long field--label-above\">\n    <div class=\"field__label\">Competitive Advantages</div>\n              <div class=\"field__item\"><ul><li>Non-blinking, Non-bleaching</li>\n<li>Chemically inert</li>\n<li>Chemically and physically stable</li>\n<li>Broad excitation</li>\n<li>Longevity</li>\n</ul></div>\n          </div>\n\n  <div class=\"field field--name-field-id field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Technology ID</div>\n              <div class=\"field__item\">TAB-2998</div>\n          </div>\n\n            <div class=\"field field--name-node-title field--type-ds field--label-hidden field__item\"><h1>\n  Fluorescent Nanodiamonds as Fiducial Markers for Microscopy\n</h1>\n</div>\n      \n  <div class=\"field field--name-field-e-numbers field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">E-Numbers</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">E-217-2015-0</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-lead-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Lead Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Neuman, Keir (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-co-inventors field--type-string field--label-inline clearfix\">\n    <div class=\"field__label\">Co-Inventors</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Samelson, Lawrence (NCI)</div>\n          <div class=\"field__item\">Manna, Asit (NCI)</div>\n          <div class=\"field__item\">Wen, Han (NHLBI)</div>\n          <div class=\"field__item\">Hong, Jennifer (NHLBI)</div>\n          <div class=\"field__item\">Yi, Chang (NCI)</div>\n          <div class=\"field__item\">Bumb, Ambika (Bikanta Corporation)</div>\n          <div class=\"field__item\">Sarkar, Susanta (NHLBI)</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-development-stages field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Development Stages</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Pre-Clinical (in vitro)</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-development-status field--type-text-long field--label-above\">\n    <div class=\"field__label\">Development Status</div>\n              <div class=\"field__item\">In vitro data available</div>\n          </div>\n\n  <div class=\"field field--name-field-research-products field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Research Products</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">Research Equipment</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-ics field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">ICs</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">NHLBI</div>\n          <div class=\"field__item\">NCI</div>\n              </div>\n      </div>\n\n  <div class=\"field field--name-field-organizations field--type-entity-reference field--label-inline clearfix\">\n    <div class=\"field__label\">Organizations</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\">NHLBI</div>\n          <div class=\"field__item\">NCI - CCR</div>\n          <div class=\"field__item\">Bikanta Corporation</div>\n              </div>\n      </div>\n\n  <div class=\"clearfix text-formatted field field--name-field-licensing-contacts field--type-text-long field--label-above\">\n    <div class=\"field__label\">Licensing Contacts</div>\n          <div class=\"field__items\">\n              <div class=\"field__item\"><a href=\"mailto:\">Specialist (ALS), Admin. Licensing</a><br /><a href=\"mailto:\"></a><br />Phone: None</div>\n              </div>\n      </div>\n\n\n  <div class=\"field field--name-field-patents field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Patents</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Patent Cooperation Treaty<br />PCT/US2016/064523<br />Filed on 2016-12-02</li>\n              <li class=\"container-card--shadow\">US Application 62/262,058<br />Filed on 2015-12-02</li>\n              <li class=\"container-card--shadow\">US Application 15/780,388<br />Filed on 2018-05-31</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaborations field--type-entity-reference field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaborations</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">Collaboration</li>\n          </ul>\n  </div>\n\n\n  <div class=\"field field--name-field-collaboration-description field--type-text-long field--label-above content-top-bottom-half-gutters\">\n    <h2 >Collaboration Description</h2>\n    <ul class=\"container-card-wrapper\">\n              <li class=\"container-card--shadow\">The National Heart, Lung and Blood Institute seeks statements of capability or interest from parties interested in collaborative research to further develop and evaluate metallic nanoparticle vesicles for cancer phototherapy. For collaboration opportunities, please contact Vincent Kolesnitchenko, Ph.D. at <a href=\"mailto:kolesniv@nhlbi.nih.gov\">kolesniv@nhlbi.nih.gov</a>.</li>\n          </ul>\n  </div>\n\n  <div class=\"field field--name-field-date-published field--type-datetime field--label-above\">\n    <div class=\"field__label\">Date Published</div>\n              <div class=\"field__item\"><time datetime=\"2016-01-11T12:00:00Z\" class=\"datetime\">Mon, 01/11/2016 - 12:00</time>\n</div>\n          </div>\n\n\n</div>\n\n", "matchLevel": "none", "matchedWords": [] }, "body": { "value": "The invention relates to fluorescent nanodiamonds (FNDs) and their uses as fiducial markers for microscopy.  FNDs are bright fluorescent probes that do not blink or bleach and have broad fluorescence excitation and emission peaks.  The fluorescence intensity can be readily controlled by the size of the FND, the number of fluorescent centers produced in the nanodiamonds, or in situ through the application of a weak magnetic field.  The particular advantage of the FND compositions of this invention are that they are particularly useful for extended imaging of a single sample over time periods that can be as long as a week or more. In an exemplary embodiment, FNDs are immobilized in a substrate that are coated with an inert top coating, like silicon dioxide, or transparent polymer (e.g. poly-L-lysine, poly-L-arginine, or siloxanes).  Generally, any suitable methods known for surface functionalization of the substrate can be used to make the composition.  In another aspect of this invention, the inventors designed software for super-resolution imaging correction method is employed to precisely determine the position coordinates of each of a set of FNDs in a plurality of images by using Gaussian fitting of the point spread function comprises each of the FNDs in the plurality of images.  The calculated correction is then used to displace each image to align the coordinates of the FNDs.  The positions of the FNDs can be tracked with sub-nanometer precision and residual drift can be reduced to the nanometer scale over hundreds of hours of tracking.", "matchLevel": "none", "matchedWords": [] }, "field_id": { "value": "TAB-2998", "matchLevel": "none", "matchedWords": [] }, "title": { "value": "Fluorescent Nanodiamonds as Fiducial Markers for Microscopy", "matchLevel": "none", "matchedWords": [] } } }
	],
	"nbHits": 8,
	"page": 0,
	"nbPages": 1,
	"hitsPerPage": 100,
	"exhaustiveNbHits": true,
	"exhaustiveTypo": true,
	"exhaustive": { "nbHits": true, "typo": true },
	"query": "",
	"params": "x-algolia-api-key=3986149b687b8f20e2468432f329f08c&x-algolia-application-id=WEXCESI5EU&hitsPerPage=100&facetFilters=[%22field_ics:NCI%22,%20[%22field_applications:Medical%20Devices%22,%20%22field_applications:Non-Medical%20Devices%22]]",
	"renderingContent": {},
	"processingTimeMS": 16,
	"processingTimingsMS": { "afterFetch": { "format": { "highlighting": 6, "snippeting": 7, "total": 14 }, "total": 14 }, "getIdx": { "load": { "total": 1 }, "total": 1 }, "request": { "roundTrip": 8 }, "total": 16 },
	"serverTimeMS": 16
}
